a multi-factor analysis showed that risk factors are ( in decreasing order ) : female gender , age above 60 , associated depression , total duration of neuroleptic treatment above 20 years , a frequently discontinued treatment , shock therapies in antecedents or associated , a diagnosis of non schizophrenic psychosis , haloperidol intake below 25 mg and fluphenazine depot above 100 mg daily .
C0040615
neuroleptic
C0018546
haloperidol